Occult Triple-Negative Breast Cancer in an 82-Year-Old Man

This breast cancer diagnosis at a glance

Subtype
Invasive Ductal Carcinoma
Biomarkers
ER negative; PR negative; HER2 negative; CK7 positive; GCDFP-15 negative; GATA-3 negative
Sex
Male
Treatment
surgery

Treatment course, step by step

  1. He chose surgery rather than chemotherapy and underwent a left modified radical mastectomy.
  2. The large axillary tumor and surrounding enlarged lymph nodes were removed.

What happened, in summary

An 82-year-old man was referred to a breast clinic after 8 months of redness over the left side of his chest and a painless mass in the left armpit. Examination found a fixed 8 × 7 cm axillary mass with red skin and a sinus draining clear fluid. No lump could be felt in either breast, and imaging did not identify a primary breast lesion.

The treatment team discussed chemotherapy and surgery with him. He preferred surgery and underwent a left modified radical mastectomy. During the operation, surgeons removed a large solid and cystic axillary tumor together with surrounding enlarged lymph nodes.

Pathology identified grade III invasive ductal carcinoma involving the breast and axilla. Four of 21 axillary lymph nodes contained cancer, and the pathologic classification was pT3N2Mx. The tumor was negative for estrogen receptor, progesterone receptor, and HER2, making it triple-negative. It was CK7 positive and negative for GCDFP-15 and GATA-3. After review by several pathologists, the findings supported occult male breast cancer: breast cancer presenting through axillary lymph-node disease even though no primary mass was visible in the breast.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar breast cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more breast cancer stories